Bio Techne | TECH - Operating Profit

Stock Price
43.30
Daily Change
-1.44 -3.22%
Monthly
-24.51%
Yearly
-11.90%
Q2 Forecast
47.36

Bio Techne reported $75.49M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Bruker USD 10.2M 66.1M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Illumina USD 239M 17M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Merck EUR 474M 738M Dec/2025
Mettler Toledo International USD 233.93M 118M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Repligen USD 19.98M 13K Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Standard Biotools USD -21.92M 1.55M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Waters USD 148M 122.52M Mar/2026